Related Experiment Video
Updated: Jan 6, 2026

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model
Published on: April 18, 2025
Long Noncoding RNA H19 Overexpression Inhibits High Glucose-Induced Oxidative Stress of Cardiomyocytes by Targeting
Xuelin Liu1,2, Qian Zhang1,2, Yuemei Zhang2
1Department of Cardiology, Gansu Provincial Central Hospital, Lanzhou, 730070, Gansu, China.
Abstract:
This study investigates the regulatory effects of long non-coding RNA H19 on miR-138-5p and their collective impact on mitochondrial oxidative stress injury in high glucose-exposed cardiomyocytes, while elucidating the underlying molecular mechanisms. The findings aim to establish a theoretical foundation for understanding the pathogenesis of diabetic cardiomyopathy. The expression levels of lncRNA H19, miR-138-5p, and MCU were quantified using RT-qPCR. H9c2 cardiomyocytes were exposed to high glucose (HG, 33 mM) in vitro to establish a diabetic cardiomyopathy (DCM) model. Regulatory targeting relationships between lncRNA H19 and miR-138-5p, as well as between miR-138-5p and mitochondrial calcium uniporter(MCU), were confirmed through dual-luciferase reporter assays. Levels of reactive oxygen species (ROS), superoxide dismutase (SOD) activity, and malondialdehyde (MDA) content were quantified to evaluate intracellular oxidative stress in cardiomyocytes. MCU protein expression was analyzed by western blotting. In DCM, H19 and MCU were downregulated; miR-138-5p was upregulated. H19 overexpression increased SOD activity and reduced ROS and MDA levels in HG-treated H9c2 cardiomyocytes. Dual-luciferase assays validated miR-138-5p binding to H19 and MCU 3'UTRs. miR-138-5p overexpression suppressed MCU protein expression. Rescue experiments demonstrated miR-138-5p overexpression or MCU silencing reversed H19-mediated oxidative stress attenuation in HG-stimulated cells. Overexpression of H19 attenuates oxidative stress by modulating the miR-138-5p/MCU axis in DCM, highlighting its potential as a diagnostic biomarker and/or therapeutic target for this condition.
Insights
Long non-coding RNA H19 protects against diabetic cardiomyopathy by regulating miR-138-5p and mitochondrial calcium uniporter (MCU). This pathway reduces oxidative stress in heart cells, offering potential therapeutic targets for diabetic heart disease.
Area of Science:
- Molecular Biology
- Cardiovascular Research
- Biochemistry
Background:
- Diabetic cardiomyopathy (DCM) involves mitochondrial oxidative stress.
- Long non-coding RNAs (lncRNAs) play roles in cellular regulation.
- The H19 lncRNA and miR-138-5p microRNA are implicated in various cellular processes.
Purpose of the Study:
- To investigate the regulatory role of lncRNA H19 on miR-138-5p.
- To determine the impact of the H19/miR-138-5p axis on mitochondrial oxidative stress in DCM.
- To elucidate the molecular mechanisms underlying DCM pathogenesis.
Main Methods:
- Quantitative real-time PCR (RT-qPCR) for gene expression analysis.
- In vitro diabetic cardiomyopathy model using high glucose-exposed H9c2 cardiomyocytes.
- Dual-luciferase reporter assays to confirm targeting relationships.
- Western blotting for protein expression analysis.
- Measurement of reactive oxygen species (ROS), superoxide dismutase (SOD), and malondialdehyde (MDA) to assess oxidative stress.
Main Results:
- In the DCM model, H19 and mitochondrial calcium uniporter (MCU) were downregulated, while miR-138-5p was upregulated.
- H19 overexpression reduced oxidative stress markers (ROS, MDA) and increased antioxidant activity (SOD) in high glucose-treated cells.
- miR-138-5p was validated to target both H19 and MCU, suppressing MCU protein expression.
- Rescue experiments confirmed that miR-138-5p overexpression or MCU silencing reversed the protective effects of H19.
Conclusions:
- lncRNA H19 attenuates mitochondrial oxidative stress in diabetic cardiomyopathy by modulating the miR-138-5p/MCU axis.
- The H19/miR-138-5p/MCU pathway is a key mechanism in DCM pathogenesis.
- H19 shows potential as a diagnostic biomarker and therapeutic target for diabetic cardiomyopathy.
Related Concept Videos
MicroRNAs
MicroRNAs
lncRNA - Long Non-coding RNAs

